New era in cancer prevention

	Tweet

Nearly two decades ago, researchers at the National Cancer Institute (NCI) and other institutions began searching for the underlying causes of cervical cancer.

That scientific quest led to today’s approval by the Food and Drug Administration of the vaccine Gardasil, which protects against infection from the two types of human papillomavirus (HPV) that cause the majority of cervical cancers worldwide.

Population studies helped to establish the link between HPV infections and the disease, revealing that while most HPV infections clear and do not lead to cancer, virtually all cases of cervical cancer were caused by HPV infection. NCI scientists Douglas Lowy, M.D., and John Schiller, Ph.D., pioneers in HPV research, then examined ways to boost the body’s immune response to prevent the cancer - causing infection. This work led to the development of the technology on which the HPV vaccine is based. 

"Genetic engineering - technology involving the manipulation of genetic material - was used to create this vaccine, which is made up of non - infectious virus - like particles (VLPs),” explained Lowy, chief of the Laboratory of Cellular Oncology in NCI’s Center for Cancer Research (CCR). “These hollow spheres, formed by a single protein from the virus (L1 protein), trigger an antibody response that is capable of protecting the body against infection by the targeted virus types.”

“Gardasil is similar to other immunizations that guard against viral infection,” said Schiller, deputy chief of the Laboratory of Cellular Oncology in CCR. “By preventing infection with two of the HPV types that can cause cervical cancer, this vaccine, if given prior to exposure to these sexually transmitted viruses, can protect women from ultimately developing cervical cancer.”

“This vaccine opens a new era in cancer prevention,” said NCI Acting Director John E. Niederhuber, M.D. “It has the potential to save women’s lives, as well as to reduce health disparities in the United States and around the world.”

Niederhuber added, “NCI’s immunology and vaccine research regarding HPV infection is far from finished. We continue to work on improved vaccines and immunization technology, to make these prevention strategies even more effective and accessible to women worldwide.”

HPVs not targeted by the current vaccines also can cause cervical cancer; women should continue to be screened with a Pap test or an approved alternative screening method.

http://www.nci.nih.gov

RELATED STORIES:
UV light improving chances of fighting cancer   Cancer detected earlier, faster, with new medical imaging, Stanford study finds   Researchers present new findings on cancer and gene therapy   Olive oil may hinder cancer process   Yoga helps fatigue, sleep in cancer survivors   American Cancer Society report details cancer prevention efforts   High ‘good’ cholesterol tied to lower cancer risk   April 18th – 24th is Natl. Minority Cancer Awareness Week   Exercise can reduce cancer treatment side effects   Just how safe is that steak?   Chemotherapy temporarily affects the structures of the human brain   People Living in Poverty at Greater Risk of Dying from Cancer   GW wins US okay for pivotal cannabis drug study   Exercise Can Reduce Side Effects of Cancer Treatment   New Hybrid virus may aid treatment of cancer   Lance Armstrong: Cancer a global problem   Cannabis ingredient can help cancer patients regain their appetites and sense of taste   Many cancer survivors still smoking and drinking   Few people are doing it, so why should I? Motivating men to seek cancer screening   NYU Langone scientists find key pathway implicated in progression of childhood cancer   Novel therapy may prove effective in treatment of 30 percent of cancers   Metastasis formation revealed in detail and real time

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]